Literature DB >> 9808369

Protective role of vagal afferents in experimentally-induced colitis in rats.

L Mazelin1, V Theodorou, J More, J Fioramonti, L Bueno.   

Abstract

The aim of this study was to evaluate the regulatory role of vagal afferents in the development of colonic inflammation induced by trinitrobenzenesulfonic acid (TNBS) in rats. Groups of Wistar rats were treated with capsaicin or its vehicle applied perivagally (sham treatment). Colonic transit time was evaluated, and, two days later, one half of the animals received an intracolonic instillation of TNBS/ethanol (40 mg/kg), and the other received saline. Inflammation was evaluated functionally (gut permeability), biochemically (myeloperoxydase activity) and histologically. Vagal capsaicin deafferentation did not modify colonic transit time. In TNBS treated groups, inflammation was enhanced by capsaicin pretreatment, as determined by an increased gut permeability, MPO activity, and histological damage score. These results suggest that vagal afferents have a protective role in TNBS-induced colitis in rats, unrelated to changes in colonic transit time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808369     DOI: 10.1016/s0165-1838(98)00113-1

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  15 in total

Review 1.  Neuroimmune alterations of ENS functioning.

Authors:  L Bueno
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve.

Authors:  H U De Schepper; J G De Man; L Van Nassauw; J-P Timmermans; A G Herman; P A Pelckmans; B Y De Winter
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

3.  Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld; John McRorie
Journal:  Dig Dis Sci       Date:  2011-05-12       Impact factor: 3.199

4.  Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons.

Authors:  Martha G Welch; Muhammad Anwar; Christine Y Chang; Kara J Gross; David A Ruggiero; Hadassah Tamir; Michael D Gershon
Journal:  Neurogastroenterol Motil       Date:  2010-03-04       Impact factor: 3.598

5.  Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation.

Authors:  Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

6.  Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.

Authors:  Jean-Eric Ghia; Patricia Blennerhassett; Stephen M Collins
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice.

Authors:  Frederik De Jonge; Luc Van Nassauw; Dirk Adriaensen; Frans Van Meir; Hugh R P Miller; Eric Van Marck; Jean-Pierre Timmermans
Journal:  Histochem Cell Biol       Date:  2003-05-27       Impact factor: 4.304

8.  S. Typhimurium challenge in juvenile pigs modulates the expression and localization of enteric cholinergic proteins and correlates with mucosal injury and inflammation.

Authors:  Calvin S Pohl; Elizabeth M Lennon; Yihang Li; Morgan P DeWilde; Adam J Moeser
Journal:  Auton Neurosci       Date:  2018-06-08       Impact factor: 3.145

Review 9.  Bioelectronics in the brain-gut axis: focus on inflammatory bowel disease (IBD).

Authors:  Nathalie Stakenborg; Guy E Boeckxstaens
Journal:  Int Immunol       Date:  2021-06-07       Impact factor: 4.823

10.  Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation.

Authors:  D Dombrowicz; S Nutten; P Desreumaux; C Neut; G Torpier; M Peeters; J F Colombel; M Capron
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.